.
MergerLinks Header Logo

New Deal


Announced

Completed

The HydraFacial Company went public via a SPAC merger with Vesper Healthcare Acquisition in a $1.1bn deal.

Financials

Edit Data
Transaction Value£823m
Consideration TypeCash, Contingent Deferred Consideration
Capital Owned-
Capital Bid For100%
EV/Sales-
EV/EBITDA-
Share Price Premium-
One Off Charge-

Tags

Edit

Private Equity

Acquisition

Medical Equipment

Single Bidder

Private

Friendly

medical devices

Majority

United States

Domestic

De-SPAC

Merger

Completed

Synopsis

Edit

The HydraFacial Company, a category-creating beauty health company, went public via a SPAC merger with Vesper Healthcare Acquisition, a special purposes acquisition company, in a $1.1bn deal. HydraFacial’s private equity owners, Linden Capital Partners and DW Healthcare Partners, retained a combined 25% stake in the business following the merger. “HydraFacial is an impressive category-creating product in an attractive and growing market and provides the perfect platform to achieve our goal of building a premier company in beauty health. We anticipate more opportunities ahead and are excited about the potential to create a valuable, industry-leading, global company in beauty health,” Brent Saunders, Vesper Healthcare CEO and Co-Founder.

© COPYRIGHT 2024 MERGERLINKS LIMITED.

ALL RIGHTS RESERVED.

15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.

CONTACT US